You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
据报内地医学检验商艾迪康已就赴港上市选定投行
阿思达克 08-21 14:38
《彭博》引述知情人士报道,获凯雷投资集团资金支持的艾迪康医学检验中心已选定银行,为其安排香港IPO事宜,最快明年上市,筹资规模约4亿美元。

据报公司选定杰富瑞及摩根士丹利担任牵头经办行,另外美国银行和中金公司亦会参与。惟上市正在筹备中,集资规模和上市时间等具体细节依存在变数。

根据官网介绍,艾迪康医学检验中心成立於2004年,为中国全国连锁经营的独立医学实验室,已在全国设立20多家医学实验室,提供2,000余项检测项目,与全国上万家医疗机构建立了合作,可每天为10万人以上就近提供检验报告。凯雷2018年与美年大健康产业控股投资艾迪康,并成为公司的单一最大股东。(ek/u)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account